Human genomics for health: Enhancing the impact of effective research. Report of the first regional meeting for the Americas. Brasília, 15–16 May 2024
Loading...
Cite
Human genomics for health: Enhancing the impact of effective research. Report of the first regional meeting for the Americas. Brasília, 15–16 May 2024. (2024). [Meeting reports]. PAHO. https://iris.paho.org/handle/10665.2/62584
Files
English; 33 pages (Updated 26 November 2024)
Date
2024-11-25
Document Number
PAHO/EIH/SK/24-0007
ISBN
eISBN
ISSN
DOI
Authors
Other Language Versions
Description
The regional meeting on Human Genomics for Health: Enhancing the Impact of Effective Research was convened in Brasilia on 15–16 May 2024 by the Pan American Health Organization (PAHO) with the support of World health Organization (WHO) headquarters, the PAHO/WHO country office in Brazil and the Department of Science and Technology, Ministry of Health, Brazil. This consultation aimed to provide a forum for the exchange of information and ideas on human genomics for health and convened over 100 participants from a broad spectrum of disciplines who contributed their expertise across relevant fields of research, including science policy, bioethics, national genomic initiatives, cancer, rare diseases, and congenital disorders. The meeting objective was to identify, discuss, and propose concrete actions for the implementation of human genomics in practice and for conducting genomic research in Member States. During the two-day meeting, this highly diverse group of experts shared experiences and best practices in applying genomics in clinical care and public health and conducting genomic research in the Americas, highlighting both successes and obstacles encountered in their work. Detailed discussions were held on the various challenges faced in the field, on the countries’ priorities and on the opportunities for advancement of genomics. There was a strong emphasis on the potential for collaborative efforts and the enhancement of partnerships within the Region of the Americas. This final report summarizes the reflection and discussion of the issues and challenges identified during the workshop and presents the key actions and recommendations to enhance equitable and effective genomics research in the Region, outlining a path forward for the Americas. The report underscore the necessity for coordinated action at national, regional, and global levels to equitably harness the transformative potential of human genomics in clinical care and public health.
Notes
Pages
36 p.
Volume
Replaces
Table of contents
Link to WHO's original document
Series
Link to WHO's original document
Category
Youtube URI
Citation
Status Mendates
License
Related items
Showing items related by metadata.
Item Opportunities for promoting open data in the Caribbean through biobanks(2025-02-11)[ABSTRACT]. The establishment of a biobank in the Caribbean represents a vital opportunity to enhance biomedical research and tackle health issues in the area. The Caribbean’s unique genetic diversity, shaped by migration and environmental factors, underscores a well-managed biobank’s potential impact on global health, especially for underrepresented groups. This paper examines biobanking’s potential in the Caribbean, focusing on precision medicine, public health improvements and regional scientific self-sufficiency. It analyzes successful models such as the UK Biobank, the All of Us Research Program at the United States’ National Institutes of Health, and Human Heredity and Health in Africa (known as H3Africa), hosted at the University of Cape Town, pinpointing key lessons on data-sharing, ethical governance and infrastructure that could be applied to the Caribbean context. The UK Biobank and H3Africa are relevant examples due to their contributions to large-scale data and health research in diverse populations. The UK Biobank project is a large-scale study with deep genetic and phenotypic data from about 500 000 participants in the United Kingdom. It offers unprecedented insights into health data through extensive follow up and collection of genome-wide genotype data. H3Africa focuses on genomics research that addresses health disparities among African populations, which parallels the Caribbean’s challenges. Its ethical governance and community engagement focus are crucial for Caribbean biobank development. This article highlights the challenges of developing biobanks, including ensuring sufficient sample storage and data security, and the need for strong governance. It recommends solutions that involve regional collaboration, stakeholder engagement and increased investment in infrastructure. Establishing a Caribbean biobank with equitable data-sharing principles can significantly enhance global genomic data sets and ensure that the benefits of precision medicine reach the Caribbean. This study promotes a strategic, ethical and inclusive approach to biobanking for long-term success.Item Meeting to Develop a Standardized Tax Share Indicator for Alcoholic and Sugar-Sweetened Beverages (Washington, D.C., 24-25 July 2018)(PAHO, 2019)[Executive summary]. Noncommunicable diseases (NCDs) are a major driver of morbidity and mortality in the Region of the Americas. They represent a major public health challenge that undermines social and economic development. The WHO Global Action Plan for Prevention and Control of Noncommunicable Diseases 2013-2020, endorsed by the 66th World Health Assembly, provides a road map and a menu of policy options. It recognizes implementing taxes on unhealthy products associated with NCDs—namely tobacco, alcoholic beverages, and sugar-sweetened beverages (SSBs)—as one of the most cost-effective regulatory policies to prevent NCDs. Although, the World Health Organization (WHO) does calculate and publish biennially a standardized and comparable indicator on tobacco taxation for all Member States, it does not count with comparable measurements of taxation on alcoholic beverages and SSBs. Such measurements are necessary to monitor tax policies, analyze trends and establish best practices in using taxation for NCD prevention. Since 2016, the Department of Noncommunicable Diseases and Mental Health (NMH) of the Pan American Health Organization/World Health Organization (PAHO/WHO) has worked towards addressing the gap measuring progress on alcoholic beverages and SSBs taxation in the Americas. NMH collected country-level information on prices as well as tax legislation and developed a methodology for calculating a tax share indicator. This indicator, estimating the share of total and excise taxes in the price of alcoholic beverages and SSBs, was calculated for ten countries. In order to receive feedbacks on its proposed methodology, discuss the progress and challenges in monitoring and evaluating taxation policies, and establish a roadmap to periodically collect tax legislation and prices and calculate the tax share for alcoholic beverages and SSBs in the Americas, NMH convened researchers and ministries of finance personnel for a two-day meeting in July 2018, in Washington D.C. The participants provided inputs on how to strengthen the proposed tax share indicator to adequately capture the intricacies, unique characteristics, and regional consumption patterns of these products. These valuable inputs will help to improve the methodology and facilitate future efforts to develop a standardized and comparable tax share indicator for alcoholic beverages and SSBs.Item Building capacity for human genetics and genomics research in Trinidad and Tobago(2015)Advances in human genetics and genomic sciences and the corresponding explosion of biomedical technologies have deepened current understanding of human health and revolutionized medicine. In developed nations, this has led to marked improvements in disease risk stratification and diagnosis. These advances have also led to targeted intervention strategies aimed at promoting disease prevention, prolonging disease onset, and mitigating symptoms, as in the well-known case of breast cancer and the BRCA1 gene. In contrast, in the developing nation of Trinidad and Tobago, this scientific revolution has not translated into the development and application of effective genomics-based interventions for improving public health. While the reasons for this are multifactorial, the underlying basis may be rooted in the lack of pertinence of internationally driven genomics research to the local public health needs in the country, as well as a lack of relevance of internationally conducted genetics research to the genetic and environmental contexts of the population. Indeed, if Trinidad and Tobago is able to harness substantial public health benefit from genetics/genomics research, then there is a dire need, in the near future, to build local capacity for the conduct and translation of such research. Specifically, it is essential to establish a national human genetics/genomics research agenda in order to build sustainable human capacity through education and knowledge transfer and to generate public policies that will provide the basis for the creation of a mutually beneficial framework (including partnerships with more developed nations) that is informed by public health needs and contextual realities of the nation.Item Technical note on the SARInet and REVELAC-i networks(PAHO, 2024-11-15)From May 14-16, 2024, the regional meeting of the Severe Acute Respiratory Infections Network (SARInet) and the Network for the Evaluation of Vaccine Effectiveness in Latin America and the Caribbean - influenza (REVELAC-i) was held in Mexico City to share experiences on surveillance, diagnosis and immunization of influenza and other respiratory viruses. More than 190 people from 36 countries participated in this meeting, in addition to professionals from the Pan American Health Organization (PAHO)/World Health Organization (WHO), the United States Centers for Disease Control and Prevention (CDC), the Public Health Agency of Canada (PHAC), the Council of Ministers of Health of Central America (COMISCA) and the Caribbean Public Health Agency (CARPHA). At the meeting, the milestones achieved by the SARInet network over the last 10 years, the main challenges and next steps were discussed. Summaries of the presentations and sessions given by the speakers are presented in this note. Prior to 2014, there was an informal network of laboratories in the Region of the Americas region, with about 30 countries conducting sentinel surveillance for severe acute respiratory infections (SARI), more than 900 sentinel centers, 28 National Influenza Centers (NICs) and 6 national laboratories. However, a mechanism for sharing information and best practices was lacking. The inaugural meeting of the SARInet network was held on May 30, 2014 in Panama, integrating laboratories and epidemiologists to improve surveillance. Over time, more strategic actors were added, such as health services networks, clinicians, general practitioners and operational research specialists, expanding a phenomenon that expanded the network to include components according to the needs of the countries. The network was operationalized and materialized through working groups focused on disease burden, genomic surveillance, clinical management and vaccine effectiveness, evolving which allowed its evolution since 2006 and improved the published guidelines and published protocols and guidelines.Item The Essential Environmental Public Health Functions. A framework to Implement the Agenda for the Americas on Health, Environment, and Climate Change 2021-2030(PAHO, 2022)This publication presents a framework to implement the Agenda for the Americas on Health, Environment, and Climate Change 2021–2030 (the Agenda) that is structured around essential public health functions focused on environmental determinants of health. The Agenda is a call to action to the health sector to lead the charge to address environmental determinants of health in the Americas. The Pan American Health Organization (PAHO) will work with Member States to achieve its goal and objective to ensure healthy lives and promote well-being for all at all ages using a sustainable and equitable approach that places a priority on reducing health inequity. The Agenda was developed under the umbrella of the WHO Global Strategy on Health, Environment, and Climate Change, and builds upon the commitments set forth in the Sustainable Health Agenda for the Americas 2018–2030 and the PAHO Strategic Plan 2020–2025. The Agenda was developed in consultation with the Technical Advisory Group and through a consensus-driven, decision-making process with Member States during the 2019–2020 period. Looking toward the achievement of Sustainable Development Goal 3, the Agenda focuses on: improving the performance of environmental public health programs and institutions; fostering environmentally resilient and sustainable health systems; and promoting environmentally healthy and resilient cities and communities. Its implementation will be context-specific, based on the needs and realities of the countries. It will benefit countries and territories by promoting good governance practices, strengthening the leadership and coordination roles of the health sector, fostering cross-sectoral action, focusing on primary prevention, and enhancing evidence and communication. It will facilitate access to human, technical, and financial resources necessary to address environmental determinants of health and ensure that the Region is fully engaged in global health, environment, and climate change processes and agreements. The objective of the Agenda is to strengthen the capacity of health actors in the health and non-health sectors to address and adapt to environmental determinants of health, prioritizing populations living in conditions of vulnerability, in order to meet Outcome 18 of the PAHO Strategic Plan 2020–2025 directly and several other outcomes of the Plan indirectly. To address and adapt to the challenges of environmental determinants of health in the Region, an integrated and evidence-informed approach within the health sector and across sectors will be needed one enabled and supported by good governance practices, adequate management mechanisms, high-level political will, and adequate human, technical, technological, and financial resources.